Nexera director reports 5,540-share ownership

Q: How many Nexera Technologies (NEXR) RSUs were granted to Revach Moshe on September 16, 2025?

Revach Moshe received 242 RSUs on September 16, 2025, with vesting commencing September 10, 2025. These RSUs vest in 12.5% quarterly installments starting December 10, 2025, with 60 vested and 182 unvested as of March 18, 2026.

Q: What are the details of the January 1, 2026 RSU grant to Revach Moshe at Nexera Technologies (NEXR)?

On January 1, 2026, Revach Moshe was granted 1,013 RSUs. These RSUs vest in equal quarterly installments of 12.5% beginning January 1, 2026, and all remained unvested as of March 18, 2026, according to the disclosure.

Q: Which RSUs for Nexera Technologies (NEXR) had fully vested for Revach Moshe by March 18, 2026?

A grant of 2,143 RSUs to Revach Moshe on February 1, 2026 had fully vested on that same date. Additional RSUs from earlier grants had partially vested, while others remained unvested as described in the filing footnote.

Q: Does the Nexera Technologies (NEXR) Form 3/A show any buy or sell transactions by Revach Moshe?

The Form 3/A reflects reported holdings rather than explicit buy or sell transactions. It lists 5,540 ordinary shares beneficially owned and breaks down RSU grants and vesting status, without specifying open-market purchases or sales in this disclosure.

Nexera Technologies Ltd director Revach Moshe reports beneficial ownership of 5,540 ordinary shares.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

3/A

Rhea-AI Filing Summary

Nexera Technologies Ltd director Revach Moshe reports beneficial ownership of 5,540 ordinary shares. This figure includes restricted share units (RSUs) with different grant and vesting schedules. As of March 18, 2026, 242 RSUs were granted on September 16, 2025, vesting quarterly at 12.5% from December 10, 2025, with 60 vested and 182 unvested. Another 1,013 RSUs were granted on January 1, 2026, also vesting quarterly at 12.5% from that date, all unvested as of March 18, 2026. A further 2,143 RSUs granted on February 1, 2026 had fully vested on that grant date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Revach Moshe

Role Director

Type	Security	Shares	Price	Value
holding	Ordinary shares	--	--	--

Holdings After Transaction: Ordinary shares — 5,540 shares (Direct)

Footnotes (1)

F1. Represents (i) 242 restricted share units ("RSUs") Granted on September 16, 2025 and the vesting commencement date is September 10, 2025, which vest in equal quarterly installments of 12.5% beginning on December 10, 2025, of which 60 RSUs have vested and 182 remain unvested as of March 18, 2026; (ii) 1,013 RSUs granted on January 1, 2026, which vest in equal quarterly installments of 12.5% beginning on January 1, 2026, all of which remain unvested as of March 18, 2026; and (iii) 2,143 RSUs granted on February 1, 2026, all of which have vested on February 1, 2026.

Key Figures

Ordinary shares owned: 5,540 shares RSUs granted Sep 16, 2025: 242 RSUs Unvested RSUs from Sep 16, 2025 grant: 182 RSUs +3 more

6 metrics

Ordinary shares owned 5,540 shares Beneficial ownership as of March 18, 2026

RSUs granted Sep 16, 2025 242 RSUs 12.5% quarterly vesting from December 10, 2025

Unvested RSUs from Sep 16, 2025 grant 182 RSUs Unvested as of March 18, 2026

RSUs granted Jan 1, 2026 1,013 RSUs 12.5% quarterly vesting from January 1, 2026; all unvested as of March 18, 2026

RSUs granted Feb 1, 2026 2,143 RSUs Fully vested on February 1, 2026

RSU vesting rate 12.5% per quarter Applies to 2025 and January 2026 RSU grants

Key Terms

restricted share units ("RSUs"), vesting commencement date, equal quarterly installments, unvested, +1 more

5 terms

vesting commencement date financial

"and the vesting commencement date is September 10, 2025"

The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.

equal quarterly installments financial

"which vest in equal quarterly installments of 12.5% beginning on December 10, 2025"

unvested financial

"of which 60 RSUs have vested and 182 remain unvested as of March 18, 2026"

granted financial

"1,013 RSUs granted on January 1, 2026, which vest in equal quarterly installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Nexera Technologies (NEXR) director Revach Moshe report in this Form 3/A?

Revach Moshe reports beneficial ownership of 5,540 ordinary shares of Nexera Technologies Ltd. This total includes several blocks of restricted share units (RSUs) with different grant dates and vesting schedules as of March 18, 2026.

How many Nexera Technologies (NEXR) RSUs were granted to Revach Moshe on September 16, 2025?

Revach Moshe received 242 RSUs on September 16, 2025, with vesting commencing September 10, 2025. These RSUs vest in 12.5% quarterly installments starting December 10, 2025, with 60 vested and 182 unvested as of March 18, 2026.

What are the details of the January 1, 2026 RSU grant to Revach Moshe at Nexera Technologies (NEXR)?

On January 1, 2026, Revach Moshe was granted 1,013 RSUs. These RSUs vest in equal quarterly installments of 12.5% beginning January 1, 2026, and all remained unvested as of March 18, 2026, according to the disclosure.

Which RSUs for Nexera Technologies (NEXR) had fully vested for Revach Moshe by March 18, 2026?

A grant of 2,143 RSUs to Revach Moshe on February 1, 2026 had fully vested on that same date. Additional RSUs from earlier grants had partially vested, while others remained unvested as described in the filing footnote.

Does the Nexera Technologies (NEXR) Form 3/A show any buy or sell transactions by Revach Moshe?

The Form 3/A reflects reported holdings rather than explicit buy or sell transactions. It lists 5,540 ordinary shares beneficially owned and breaks down RSU grants and vesting status, without specifying open-market purchases or sales in this disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/07/2026 - 04:05 PM EDT

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Revach Moshe

(Last)

(First)

(Middle)

7 MEZADA STREET

(Street)

BNEI BRAK

5126112

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Nexera Technologies Ltd [ NEXR ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)
03/18/2026

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares	5,540⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

1. Represents (i) 242 restricted share units ("RSUs") Granted on September 16, 2025 and the vesting commencement date is September 10, 2025, which vest in equal quarterly installments of 12.5% beginning on December 10, 2025, of which 60 RSUs have vested and 182 remain unvested as of March 18, 2026; (ii) 1,013 RSUs granted on January 1, 2026, which vest in equal quarterly installments of 12.5% beginning on January 1, 2026, all of which remain unvested as of March 18, 2026; and (iii) 2,143 RSUs granted on February 1, 2026, all of which have vested on February 1, 2026.

	/s/ Moshe Revach	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR